 | Avadel Pharmaceuticals plc | |||
| NGM : AVDL || Location: Ireland | ||||
$18.09+1.09 (+6.41%) |
2.31 M | 16.52 - 18.85 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 10.395 M |
| March 15, 2024 | 10.474 M |
| Feb. 29, 2024 | 10.741 M |
| Feb. 15, 2024 | 8.862 M |
| Jan. 31, 2024 | 8.481 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.26 | -0.29 | -9.64% |
| 09/30/2023 | -0.38 | -0.41 | -7.98% |
| 06/30/2023 | -0.39 | -0.83 | -111.73% |
| 03/31/2023 | -0.38 | -0.48 | -24.87% |
| 12/31/2022 | -0.28 | -0.46 | -66.43% |
AVDL Basic Data
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Shares Outstanding | 90.577M | Shares Float | 66.689M |
| Short Float | 10.395M | Market Cap | 1539.81M |
| Institution ownership | 64.21% | Insider ownership | 4.899% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -2.00 | Forward EPS | 1.02 |